The Journal of Contemporary Dental Practice

Register      Login



Volume / Issue

Online First

Related articles

VOLUME 8 , ISSUE 1 ( January, 2007 ) > List of Articles


Short-term Success of Osseointegrated Dental Implants in HIV-positive Individuals: A Prospective Study

Catherine M. Flaitz, C. Mark Nichols, Gene C. Stevenson, Patricia C. Riano, Antonio J. Moretti, Robert L. Engelmeier

Citation Information : Flaitz CM, Nichols CM, Stevenson GC, Riano PC, Moretti AJ, Engelmeier RL. Short-term Success of Osseointegrated Dental Implants in HIV-positive Individuals: A Prospective Study. J Contemp Dent Pract 2007; 8 (1):1-10.

DOI: 10.5005/jcdp-8-1-1

License: CC BY-NC 3.0

Published Online: 01-03-2008

Copyright Statement:  Copyright © 2007; The Author(s).



Except for the occasional case report, there are no studies evaluating the success rate of osseointegrated dental implants in individuals infected with the human immunodeficiency virus (HIV). This study investigated the short-term clinical outcome of implant placement in a group of HIV-positive and HIV-negative individuals who required complete dentures.

Methods and Materials

Edentulous subjects were recruited from an HIV-dedicated clinic and a dental school clinic. Two BioHorizons® dental implants were placed in the anterior mandible to support an overdenture opposing a maxillary denture. Outcome measurements obtained six months after activation of implants were presence of pain, mobility, soft tissue status, and radiographic bone level. Descriptive statistics were used.


Twenty-nine edentulous adults, including 20 HIV-positive subjects (test) and nine HIV-negative subjects (control), participated. The test group had six females, 14 males; 13 Whites, four African-Americans, and three Hispanics with a mean age of 48.9 years (range: 35-59). The mean CD4 count was 467 cells/mm3 (range: 132-948). The control group had six females, three males; seven Whites, and two Hispanics with a mean age of 65.3 years (range: 50-82). Short-term success rate was 100% for both groups. No difference in clinical outcome was found between the groups.


This study demonstrated dental implants are well tolerated and have predictable outcomes for HIV-infected individuals for the duration of the study and probably over an even longer term.


Stevenson GC, Riano PC, Moretti AJ, Nichols CM, Engelmeier RL, Flaitz CM. Short-term Success of Osseointegrated Dental Implants in HIV-positive Individuals: A Prospective Study. J Contemp Dent Pract 2007 January;(8)1:001-010.

PDF Share
  1. Clinician's Guide to Treatment of HIV-infected Patients. 3rd ed. Baltimore, MD: American Academy of Oral Medicine; 2001.
  2. Oral manifestations of HIV infection. Annals Intern Med 1996;125(6):485-496.
  3. Oral manifestations of HIV infection. AIDS Clinical Care 1997;9(4):29-33.
  4. Oropharyngeal lesions in AIDS. Gastrointest Endosc Clin N Am 1998;8:783-809.
  5. Practical considerations in the treatment of the HIV-infected patient. Dent Clinics N Am 1994;38(3):403-423.
  6. Rapid progression of bone loss in HIV-associated necrotizing ulcerative stomatitis. J Periodontol 1998;69(6):710-716.
  7. Longitudinal evaluation of loss of attachment in HIV-infected women compared to HIV-uninfected women. J Periodontol 2006;77(5):773-779.
  8. Relations among CD4 lymphocyte count nadir, antiretroviral therapy, and HIV-1 disease progression: Results from the Euro-SIDA study. Ann Med 1999;130:570-577.
  9. Treatment of HIV infection. In:Crowe S, Hoy J, Mills J (eds). Management of the HIVinfected patient. 2nd ed. London: Martin Dunitz Ltd.;2002:117-128.
  10. Marked declines in human immunodeficiency virusrelated mortality in Chicago in women, African Americans, Hispanics, young adults, and injection drug user, from 1995 through 1997. Arch Intern Med 2000;160:365-369.
  11. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. New Engl J Med 1998;338:856-860.
  12. Montreal, Quebec, Canada. May 24, 2002. Int J Prosthodont 2002;15(4):413-414.
  13. Treatment options for mandibular implant overdentures: An organized approach. In: Misch CE (ed). Dental Implant Prosthetics. St. Louis, Mosby; 2005:206-227.
  14. The long-term efficacy of currently used dental implants: A review and proposed criteria of success. Int J Oral Maxillofac Implants 1986;1:11-25.
  15. Assessment of implant stability as a prognostic determinant. Int J Prosthodont 1998;11(5):491-501.
  16. Osseointegrated oral implants. A Swedish multicenter study of 8139 consecutively inserted Nobelpharma implants. J Periodontol 1988;59(5):287-296.
  17. Risk factors associated with dental implants in healthy and medically compromised patients. Int J Oral Maxillofac Implants 1992;7:367-372.
  18. Medical evaluation of the implant patient. In: Misch CE (ed). Contemporary Implant Dentistry. 2nd ed. St. Louis, Mosby; 1999:33-65.
  19. Immediate placement of an endosseous root-form implant in an HIVpositive patient: Report of a case. J Periodontol 1998;69(10):1167-1171.
  20. Implants in an HIV positive patient: A case report. Int J Oral Maxillofac Implants 2004;19:425-430.
  21. Dental implants in the HIV-positive patient – Case report and review of the literature. Gen Dent 2005;53(6):434-437.
  22. Implants in HIV-positive patients: 3 case reports. J Oral Maxillofac Surg 2006;64:1199-1203.
  23. Available bone and implant dentistry. In: Mish CE (ed). Dental Implant Prosthetics. St. Louis, Mosby; 2005:105-129.
  24. Bone density: A key determinant for clinical success. In: Misch CE (ed). Dental Implant Prosthetics. St. Louis, Mosby; 2005:130-141.
  25. A 15 year study of osseointegrated implants in the treatment of the edentulous jaw. Int J Oral Surg 1981;6:387-416.
  26. Surgical procedures. In:Brånemark P-I, Zarb GA, Albrektsson T (eds). Tissue-Integrated Prostheses. Chicago, Quintessence Publishing Co.; 1985:211-232.
  27. The influence of preoperative antibiotics on success of endosseous implants up to and including stage II surgery: A study of 2,641 implants. J Oral Maxillofac Surg 1997;55(suppl 5):19-24.
  28. Inter- and intraobserver variability in radiographic bone level assessment at Brånemark fixtures. Clin Oral Implants Res 1998 Aug;9(4):243-250.
  29. Implants for partial edentulism. J Dent Educ 1988;52:725-736.
  30. Outcome failures of endosseous implants from a clinical training center. Compendium 1996;17(9):848-850, 852-854, 856 passim.
  31. Colonization of Candida species in denture wearers with emphasis on HIV infection: A literature review. J Prosthet Dent 2005;93:288-293.
  32. Radiation therapy of the oral cavity: Sequela and management, Part 2. Head Neck 1979;1:392-408.
  33. Saliva: A significant factor in removable prosthodontic treatment. J Prosthet Dent 1987;57:57-66.
  34. Complete-denture therapy for the geriatric patient. Dent Clinics N Am 1996;40(1):239-54.
  35. Oral candidiasis. Am J Med 1984;77(4D):28-33.
  36. Oral complications of cancer radiotherapy. Postgrad Med 1977;61(2):85-92.
  37. The prevalence of Candida albicans populations in the mouths of complete denture wearers. New Microbiol 1998 Jan;21(1):41-48.
  38. Complications of dental surgery in persons with HIV disease. Oral Surg Oral Med Oral Pathol 1993;75:165-167.
  39. Dental complications after treating patients with AIDS. J Am Dent Assoc 1994;125:296-301.
  40. HIV status and the risk of post-extraction complications. J Dent Res 1997;76(10):1644-1652.
  41. A systematic review of complication risks for HIV-positive patients undergoing invasive dental procedures. J Am Dent Assoc 2002;113(2):195-203.
  42. The association between the failure of dental implants and cigarette smoking. Int J Oral Maxillofac Implants 1993;8:609-615.
  43. The effect of smoking on early implant failure. Clin Oral Impl Res 1994;5:260-264.
  44. The relationship of smoking on peri-implant tissue: A retrospective study. J Prosthet Dent 1996;76:592-596.
  45. The influence of smoking on 3-year clinical success of osseointegrated dental implant. Ann Periodontol 2000;5:79-89.
  46. The effect of cigarette smoking on dental implants and related surgery. Implant Dent 2005;14(4):357-361.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.